🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 12 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/05/2015 | 55,65 | 56,23 | 53,91 | 54,44 | -2,14% | 4,18% | 638.154 |
| 26/05/2015 | 55,42 | 56,11 | 55,08 | 55,63 | -0,56% | 1,86% | 401.231 |
| 22/05/2015 | 55,46 | 56,19 | 55,22 | 55,94 | +0,49% | 1,75% | 339.676 |
| 21/05/2015 | 53,92 | 55,84 | 53,92 | 55,66 | +2,82% | 3,56% | 607.216 |
| 20/05/2015 | 54,19 | 54,77 | 53,16 | 54,14 | -0,17% | 2,98% | 370.614 |
| 19/05/2015 | 54,59 | 55,83 | 53,79 | 54,23 | -1,01% | 3,74% | 411.170 |
| 18/05/2015 | 52,53 | 55,14 | 52,34 | 54,78 | +4,29% | 5,33% | 801.981 |
| 15/05/2015 | 52,34 | 52,86 | 51,93 | 52,53 | +0,11% | 1,78% | 277.159 |
| 14/05/2015 | 52,58 | 53,02 | 51,80 | 52,48 | +0,37% | 2,31% | 544.699 |
| 13/05/2015 | 52,83 | 52,98 | 51,10 | 52,28 | -0,39% | 3,57% | 551.592 |
| 12/05/2015 | 52,89 | 53,33 | 51,98 | 52,49 | -0,34% | 2,55% | 642.803 |
| 11/05/2015 | 51,15 | 55,12 | 50,77 | 52,67 | +4,87% | 8,49% | 1.007.646 |
| 08/05/2015 | 49,54 | 50,68 | 48,79 | 50,22 | +1,91% | 3,82% | 553.195 |
| 07/05/2015 | 49,09 | 49,79 | 48,12 | 49,28 | +0,70% | 3,39% | 413.414 |
| 06/05/2015 | 48,91 | 49,66 | 47,94 | 48,94 | +1,00% | 3,52% | 652.902 |
| 05/05/2015 | 49,78 | 49,91 | 47,99 | 48,45 | -2,73% | 3,86% | 401.872 |
| 04/05/2015 | 49,91 | 51,25 | 49,10 | 49,81 | +0,06% | 4,30% | 429.604 |
| 01/05/2015 | 48,92 | 50,41 | 48,58 | 49,78 | +2,78% | 3,74% | 610.743 |
| 30/04/2015 | 50,85 | 51,77 | 47,83 | 48,43 | -5,21% | 7,74% | 730.487 |
| 29/04/2015 | 50,95 | 52,18 | 49,98 | 51,10 | +0,47% | 4,32% | 774.890 |
| 28/04/2015 | 54,50 | 55,14 | 50,28 | 50,86 | -6,61% | 8,92% | 1.222.929 |
| 27/04/2015 | 56,01 | 56,44 | 54,00 | 54,46 | -2,73% | 4,37% | 733.212 |
| 24/04/2015 | 55,47 | 56,03 | 54,90 | 55,99 | +0,93% | 2,04% | 324.768 |
| 23/04/2015 | 54,80 | 56,13 | 54,12 | 55,47 | +1,38% | 3,68% | 543.577 |
| 22/04/2015 | 55,30 | 56,13 | 53,94 | 54,72 | -0,66% | 3,97% | 508.953 |
| 21/04/2015 | 53,68 | 55,41 | 53,14 | 55,08 | +3,38% | 4,23% | 647.612 |
| 20/04/2015 | 53,79 | 54,15 | 52,02 | 53,28 | -0,52% | 3,95% | 1.021.432 |
| 17/04/2015 | 53,69 | 54,09 | 52,83 | 53,56 | -1,15% | 2,35% | 1.106.230 |
| 16/04/2015 | 53,05 | 54,38 | 52,51 | 54,18 | +2,27% | 3,52% | 1.119.375 |
| 15/04/2015 | 52,09 | 53,09 | 51,42 | 52,98 | +2,67% | 3,22% | 665.085 |